menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Novo Nordisk stock trades at 4-year-low on the back of disappointing Alzheimer’s trial

1 0
latest
The stock of the Wegovy and Ozempic maker is down nearly 50% year to date.

© Fortune